The global Heart-Lung Machine Market was valued at USD 2.2 billion in 2025 and is projected to grow from USD 2.4 billion in 2026 to USD 3.7 billion by 2033, registering a CAGR of 6.4% from 2026 to 2033. Market growth is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs), the growing number of open-heart surgeries, technological advancements in perfusion systems, and the continuous expansion of healthcare infrastructure across both developed and emerging economies.
Heart-lung machines play a critical role in cardiothoracic procedures by temporarily taking over the functions of the heart and lungs during surgery. These systems ensure continuous blood circulation and oxygenation, enabling surgeons to perform complex cardiac interventions with greater precision and safety. As cardiovascular disorders remain one of the leading causes of mortality worldwide, the demand for advanced cardiopulmonary bypass systems continues to rise.
The increasing adoption of extracorporeal life support technologies, including extracorporeal membrane oxygenation (ECMO), is further strengthening market growth. Hospitals and specialty cardiac centers are increasingly investing in advanced perfusion equipment to improve patient outcomes and support complex surgical procedures.
Growing Heart and Lung Transplant Programs Fuel Market Expansion
The global increase in heart and lung transplantation procedures is creating substantial demand for advanced perfusion systems and related consumables. Rising transplant success rates, improved donor organ management, and expanding transplant programs are encouraging healthcare institutions to invest in sophisticated heart-lung technologies.
Heart-lung machines remain essential during transplant surgeries, ensuring stable circulation and oxygenation throughout the procedure. In addition, advancements in organ preservation technologies are supporting the broader adoption of extracorporeal support systems within transplant programs.
The growing burden of end-stage heart and lung diseases, combined with increasing awareness regarding organ transplantation, is expected to continue driving market demand throughout the forecast period.
Emerging Trend: Expansion of Extracorporeal Support Technologies
One of the most significant trends influencing the heart-lung machine market is the growing adoption of ECMO and advanced perfusion technologies beyond traditional operating room environments. Portable and mobile ECMO systems are increasingly being utilized in emergency transport services, ambulances, air medical transport, and critical care settings.
This trend is expanding the clinical utility of extracorporeal support technologies and creating new opportunities for manufacturers developing compact, efficient, and highly mobile perfusion systems.
Key Market Trends & Insights
Consumables Segment Leads Product Demand
By product, the consumables segment accounted for the largest revenue share of 68.24% in 2025.
Growing cardiovascular disease prevalence and rising surgical procedure volumes continue to drive demand for consumables.
Single-use circuits, oxygenators, tubing sets, filters, and cannulas are essential components utilized during cardiopulmonary bypass procedures.
Continuous innovation in consumable design is improving procedural efficiency, patient safety, and clinical outcomes.
Recent advancements in portable ECMO systems are further increasing demand for compatible consumable products across various healthcare environments.
Coronary Artery Bypass Grafting (CABG) Remains the Largest Application
By application, the Coronary Artery Bypass Grafting (CABG) segment held the largest market share of 31.56% in 2025.
Increasing incidences of coronary artery disease continue to drive CABG procedure volumes globally.
Growing numbers of elderly patients and individuals with multiple comorbidities are contributing to higher demand for cardiopulmonary bypass support during complex surgeries.
Advances in surgical techniques and perfusion technologies are improving procedural success rates and patient recovery outcomes.
The continued preference for CABG procedures in treating severe coronary artery disease is expected to sustain long-term demand for heart-lung machines.
Public Healthcare Institutions Drive Equipment Adoption
By end-use, the public healthcare institutions segment accounted for the largest revenue share of 55.38% in 2025.
Government-funded hospitals perform a significant proportion of cardiac surgeries worldwide.
Public investment in advanced cardiovascular care infrastructure continues to support procurement of heart-lung machines and associated equipment.
Increasing healthcare budgets and initiatives aimed at improving access to specialized cardiac care are further strengthening market growth.
Hospital-Manufacturer Collaborations Accelerate Innovation
Strategic collaborations between device manufacturers and healthcare institutions are playing an increasingly important role in market development. Partnerships enable faster clinical validation of new technologies, streamlined regulatory approvals, and improved adoption of advanced perfusion systems.
Manufacturers are working closely with leading cardiac centers to evaluate next-generation cardiopulmonary bypass platforms and ECMO technologies under real-world clinical conditions. These collaborations are accelerating innovation while supporting broader market penetration.
Regional Highlights
North America Maintains Market Leadership
North America accounted for the largest revenue share of 52.06% in 2025.
The region benefits from advanced healthcare infrastructure, high procedural volumes, strong reimbursement systems, and early adoption of innovative medical technologies.
Significant investments in cardiovascular research and transplant programs continue to support market expansion.
Looking for more specific insights? Customize this report to suite your business needs
Asia Pacific Emerges as the Fastest-Growing Market
Asia Pacific is projected to register the highest CAGR during 2026–2033.
Rising cardiovascular disease incidence, expanding healthcare infrastructure, and growing healthcare expenditure are driving regional demand.
Increasing access to advanced cardiac procedures and medical technologies is expected to further accelerate market growth.
United States Dominates Country-Level Revenue
The U.S. accounted for 88.04% of the North American heart-lung machine market in 2025.
The country's leadership position is supported by high volumes of cardiac surgeries, advanced transplant programs, and strong healthcare spending.
Continuous innovation and extensive adoption of ECMO technologies continue to strengthen demand.
Market Size & Forecast
Market Size (2025): USD 2.2 Billion
Estimated Market Size (2026): USD 2.4 Billion
Projected Market Size (2033): USD 3.7 Billion
CAGR (2026–2033): 6.4%
Largest Regional Market: North America
Fastest-Growing Region: Asia Pacific
Leading Country Market: United States
Competitive Landscape
The global heart-lung machine market is characterized by continuous technological innovation and strategic collaborations among leading manufacturers and healthcare providers. Companies are focusing on expanding their product portfolios while improving system efficiency, portability, and patient safety.
Key competitive strategies include:
Product portfolio expansion
Strategic partnerships and collaborations
Mergers and acquisitions
Geographic expansion initiatives
Development of advanced ECMO systems
Investments in next-generation perfusion technologies
Research and development programs
The increasing emphasis on minimally invasive cardiac procedures, enhanced perfusion monitoring, and portable extracorporeal support systems is expected to shape future competitive dynamics within the market.
In addition, advancements in ex vivo organ preservation technologies, including ex vivo lung perfusion (EVLP), are creating new opportunities for perfusion-based systems closely aligned with heart-lung machine technologies.
Key Heart-Lung Machine Companies
The following companies are among the leading participants in the global heart-lung machine market:
Medtronic
Terumo Corporation
LivaNova PLC
Getinge AB
Braille Biomedical
Nipro Corporation do Brasil (NIPRO)
Surge Cardiovascular
EUROSETS
Technowood America Corporation
Fresenius Medical Care
MERA (Senko Medical Instrument Mfg. Co., Ltd.)
Conclusion
The global heart-lung machine market is expected to witness sustained growth as cardiovascular disease prevalence continues to rise and demand for advanced cardiac surgeries increases worldwide. The growing number of heart and lung transplant procedures, expanding ECMO utilization, technological advancements in perfusion systems, and ongoing investments in healthcare infrastructure are creating favorable conditions for market expansion.
North America remains the dominant market, while Asia Pacific is emerging as the fastest-growing region due to increasing healthcare investments and expanding access to specialized cardiac care. As healthcare providers continue to prioritize improved surgical outcomes, patient safety, and advanced extracorporeal support technologies, the heart-lung machine market is expected to remain a critical component of the global cardiovascular care ecosystem through 2033.
Looking for a report customized to your requirements? Explore our Custom Research Offering
Grand View Research offers
Focused market intelligence reports on specific geographies or high-growth segments
Extended forecast timelines for long-term planning
Competitor Benchmarking and Supply Chain Analysis
Inclusion of regulatory and policy assessments
Inclusion of custom data models, KPIs, or applications unique to your business
Specific high-impact Data Decks and Tables to support effective decision making
And much more…
Comments
Log in or sign up to join the conversation.